(Q40511110)

21 September 2017

Salivary Antipyrine Kinetics in Hepatic and Renal Disease and in Patients on Anticonvulsant Therapy (English)

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04401.X

11 June 2022

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04401.X

11 June 2022

author name string

A. W. Harman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A270989

11 June 2022

R. K. Penhall

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A270989

11 June 2022

B. G. Priestly

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A270989

11 June 2022

D. B. Frewin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A270989

11 June 2022

P. J. Phillips

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A270989

11 June 2022

A. R. Clarkson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A270989

11 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=270989

11 June 2022

publication date

1 August 1977

1 reference

full work available at URL

21 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1445-5994.1977.tb04401.x

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04401.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1445-5994.1977.tb04401.x/fullpdf

11 June 2022

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04401.X

Australian and New Zealand journal of medicine

11 June 2022

published in

1 reference

21 September 2017

7

1 reference

21 September 2017

4

1 reference

21 September 2017

385-390

1 reference

Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.

21 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1977.TB04401.X

Metabolism of amylobarbitone in patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1977.TB04401.X

Plasma half-life of phenylbutazone in patients with impaired liver function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1977.TB04401.X

Plasma Disappearance and Cerebral Effects of Chlorpromazine in Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1977.TB04401.X

The plasma half-life of antipyrine in chromic uraemic and normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1977.TB04401.X

Elimination of antipyrine from saliva as a measure of metabolism in man

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04401.X

The fate of antipyrine in man

11 June 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04401.X

Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow

11 June 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04401.X

Determinants of serum antipyrine half-lives in patients with liver disease

11 June 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04401.X

Clearance of antipyrine-dependence of quantitative liver function

11 June 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04401.X

Corticosteroids in liver disease: Studies on the biological conversion of prednisone to prednisolone and plasma protein binding

11 June 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04401.X

Pharmacodynamics of Carbenicillin in Hepatic and Renal Failure

11 June 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04401.X

The influence of heart failure, liver disease, and renal failure on the disposition of lidocaine in man

11 June 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04401.X

Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis

11 June 2022

Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease

12

0 references

13

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04401.X

RATE OF METABOLISM OF TOLBUTAMIDE IN TEST SUBJECTS WITH LIVER DISEASE OR WITH IMPAIRED RENAL FUNCTION

12 February 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04401.X

Disappearance of phenazone from plasma in patients with obstructive jaundice

12 February 2023

18

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04401.X

The metabolism of antipyrine in patients with chronic renal failure

12 February 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04401.X

Diphenylhydantoin Metabolism in Uremia

12 February 2023

21

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04401.X

The metabolism of phenacetin in patients with renal disease

12 February 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04401.X

Urinary D-glucaric-acid excretion as a test for hepatic enzyme induction in man

12 February 2023

23

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04401.X

Effect of diphenylhydantoin on hepatic drug hydroxylation

12 February 2023

24

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04401.X

12 February 2023

Identifiers

1 reference

21 September 2017

1 reference